Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026)

Alto Neuroscience has reported Interest & Investment Income over the past 4 years, most recently at $1.6 million for Q1 2026.

  • Quarterly results put Interest & Investment Income at $1.6 million for Q1 2026, down 14.56% from a year ago — trailing twelve months through Mar 2026 was $6.3 million (down 30.52% YoY), and the annual figure for FY2025 was $6.6 million, down 25.4%.
  • Interest & Investment Income reached $1.6 million in Q1 2026 per ANRO's latest filing, roughly flat from $1.6 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.7 million in Q2 2024 and bottomed at $230000.0 in Q1 2023.
  • Median Interest & Investment Income over the past 4 years was $1.6 million (2025), compared with a mean of $1.5 million.
  • The largest annual shift saw Interest & Investment Income skyrocketed 577.39% in 2024 before it crashed 38.72% in 2025.
  • Over 4 years, Interest & Investment Income stood at $738000.0 in 2023, then soared by 189.3% to $2.1 million in 2024, then dropped by 26.89% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
  • Business Quant data shows Interest & Investment Income for ANRO at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.